IN VITRO RECEPTOR ACTIVITY DETERMINATIONS FOR MEDICATIONS DEVELOPMENT

Release Date:  January 31, 2001

NOTICE:  NOT-DA-01-021

RFP AVAILABLE:  N01DA-1-8816

National Institute on Drug Abuse

The National Institute on Drug Abuse (NIDA) is soliciting proposals 
from qualified organizations having in-house capability to perform in 
vitro receptor binding and functional activity assays.  Proprietary 
test compounds will be evaluated in established assays, and the 
resulting data will be utilized by the Cocaine and Opiate Treatment 
Discovery Programs of the NIDA Division of Treatment Research and 
Development.  Offerors must indicate possession of current DEA 
registration for Schedule II-V substances prior to award and apply for 
Schedule I registration at the time of award. 

It is estimated that a 4 year incrementally funded completion-type 
contract will be awarded from this procurement.  Estimated issuance 
date of RFP No. N01DA-1-8816 is February 6, 2001 and responses are due 
to be received in the Contracting Officer"s office 45 calendar days 
thereafter.

RFP No. N01DA-1-8816 will be available electronically on or about 
February 6, 2001, and may be accessed through the Internet at the 
following address:  (http://www.nida.nih.gov/RFP/RFPList.html)  
Please note that the RFP for this acquisition will be streamlined to 
include only the Work Statement, Deliverables and Reporting 
Requirements, Special Requirements and Mandatory Qualifications, 
Technical Evaluation Criteria, and other necessary Proposal Preparation 
Instructions.  All information required for submission of an offer will 
be contained in or accessible through the electronic RFP package.  
Following proposal submission and the initial review process, offerors 
comprising the competitive range may be requested to provide additional 
documentation to the Contracting Officer.  Response to the RFP will be 
due on or about March 20, 2001.  Any responsible offeror may submit a 
proposal, which will be considered by the Government.  This 
advertisement does not commit the Government to award a contract.  

Point of Contact:  Michelle L. Scala, Contract Specialist
National Institute on Drug Abuse, NIH
Contracts Management Branch, OPRM
6001 Executive Boulevard
Room 3105, MSC 9543
Bethesda, Maryland  20892-9543
Email:  [email protected]
Telephone:  (301) 443-6677
Fax:  (301) 443-7595

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®